FIELD: biotechnology, immunology, medicine.
SUBSTANCE: antigens for vaccine against influenza virus are prepared by preparing the crude viral concentrate and purification of viral concentrate is carried out by gel-filtration method on carrier "DIOL-500". Then viral concentrate is cleaved with detergent β-octylglucoside and vaccine antigens are isolated by gel-filtration method on carrier Sephadex G-50. Advantage of invention involves enhancing prophylactic properties of antigens of influenza viruses. Invention can be used in producing anti-influenza vaccine used in prophylaxis of influenza in population for aim reducing risk and complications of the disease.
EFFECT: improved preparing method.
6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| INACTIVATED SPLIT INFLUENZA VACCINE AND PREPARATION METHOD THEREOF | 2015 |
|
RU2584594C1 |
| METHOD FOR OBTAINING A TETRAVALENT VACCINE FOR THE PREVENTION OF INFLUENZA | 2020 |
|
RU2754398C1 |
| METHOD OF PRODUCING ANTIGEN OR ANTIGENS FOR PRODUCTION OF INFLUENZA VACCINE AND A VACCINE BASED ON IT | 2019 |
|
RU2710239C1 |
| PENTAVALENT SUBUNIT VACCINE AGAINST RESPIRATORY INFECTIONS AND METHOD OF ITS PREPARATION | 2022 |
|
RU2804948C2 |
| METHOD OF PRODUCING TETRAVALENT SUBUNIT INFLUENZA VACCINE | 2019 |
|
RU2740751C1 |
| INFLUENZA VACCINE AND METHOD FOR PREPARING IT | 2010 |
|
RU2446824C2 |
| METHOD OF PREPARING INFLUENZA VACCINE | 2009 |
|
RU2423995C1 |
| METHOD FOR PRODUCTION OF TETRAVALENT SUBUNIT VACCINE AGAINST INFLUENZA WITHOUT ADJUVANTS | 2020 |
|
RU2741003C1 |
| INFLUENZA VACCINE | 2014 |
|
RU2546861C1 |
| TEST SYSTEM FOR DETERMINING SPECIFIC ACTIVITY OF INFLUENZA VIRUS AND METHOD FOR ITS OBTAINING | 2022 |
|
RU2804067C1 |
